125 related articles for article (PubMed ID: 10707936)
1. Cytokine balance and lipid antigen presentation in the NOD mouse pancreas during development of insulitis.
Teros T; Hakala R; Ylinen L; Liukas A; Arvilommi P; Sainio-Pöllänen S; Veräjänkorva E; Pöllänen P; Simell O
Pancreas; 2000 Mar; 20(2):191-6. PubMed ID: 10707936
[TBL] [Abstract][Full Text] [Related]
2. The role of lipid antigen presentation, cytokine balance, and major histocompatibility complex in a novel murine model of adoptive transfer of insulitis.
Ylinen L; Teros T; Liukas A; Arvilommi P; Sainio-Pöllänen S; Veräjänkorva E; Pöllänen P; Simell O
Pancreas; 2000 Mar; 20(2):197-205. PubMed ID: 10707937
[TBL] [Abstract][Full Text] [Related]
3. Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas.
Rothe H; Ito Y; Kolb H
J Mol Med (Berl); 2001 May; 79(4):190-7. PubMed ID: 11409710
[TBL] [Abstract][Full Text] [Related]
4. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
5. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
6. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.
Walz M; Overbergh L; Mathieu C; Kolb H; Martin S
Horm Metab Res; 2002 Oct; 34(10):561-9. PubMed ID: 12439784
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
[TBL] [Abstract][Full Text] [Related]
8. Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice.
Alleva DG; Pavlovich RP; Grant C; Kaser SB; Beller DI
Diabetes; 2000 Jul; 49(7):1106-15. PubMed ID: 10909966
[TBL] [Abstract][Full Text] [Related]
9. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M
Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384
[TBL] [Abstract][Full Text] [Related]
10. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
11. Both TH1 and TH2 cytokine mRNAs are expressed in the NOD mouse pancreas in vivo.
Faulkner-Jones BE; Dempsey-Collier M; Mandel TE; Harrison LC
Autoimmunity; 1996; 23(2):99-110. PubMed ID: 8871765
[TBL] [Abstract][Full Text] [Related]
12. Expression of interferon inducible protein-10 in pancreas of mice.
Li D; Zhu SW; Liu DJ; Liu GL
World J Gastroenterol; 2005 Aug; 11(30):4750-2. PubMed ID: 16094723
[TBL] [Abstract][Full Text] [Related]
13. Serum IFN-gamma and IL-10 levels are associated with disease progression in non-obese diabetic mice.
Schloot NC; Hanifi-Moghaddam P; Goebel C; Shatavi SV; Flohé S; Kolb H; Rothe H
Diabetes Metab Res Rev; 2002; 18(1):64-70. PubMed ID: 11921420
[TBL] [Abstract][Full Text] [Related]
14. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
15. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
16. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
Rivereau AS; You S; Lalain S; Gouin E; Saï P
Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
18. Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior.
Hänninen A; Salmi M; Simell O; Jalkanen S
Diabetes; 1996 Sep; 45(9):1173-80. PubMed ID: 8772718
[TBL] [Abstract][Full Text] [Related]
19. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
20. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
